comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 01:13:48 - browse：693

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter:

The Food and Drug Administration’s decision in June to grant conditional approval to a gene therapy for Duchenne muscular dystrophy was a watershed moment for the treatment of the neuromuscular disease, and a big win for its maker, Sarepta Therapeutics. Confirming the gene therapy’s benefit — and potentially broadening its use to include older boys — will be determined by a Phase 3 clinical trial that will read out later this quarter.

Pfizeris developing its own gene therapy for Duchenne in a fully enrolled Phase 3 study with final results expected in 2024. But before the verdict is revealed, Pfizer intends to conduct an interim analysis later this quarter. The most likely outcome of this early look will be a determination to continue the study to its completion. But surprises — including an early stop for overwhelming efficacy — can’t be ruled out.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Robert Kennedy Jr.'s presidential campaign attracts GOP

WSS

Exact Sciences stock tumbles despite strong cancer detection sales

H5N1 bird flu found in pasteurized milk: what we know

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Cancer researcher Catriona Jamieson is sending tumors into space

Getting Alzheimer's drug Leqembi to patients can be a challenge

Medical bills so high, Medicare adding extra digits to claim forms

explore

comprehensive

hotspot

Sports medicine is finally prioritizing gender equality

Manchin plays down potential 3rd

Anesthesiologist group: stop taking Ozempic before surgery

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

What does generative AI mean for health care? We asked experts

Key Senate committee drafts bipartisan bill to stem drug shortages

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cancer researcher Catriona Jamieson is sending tumors into space

23andMe had bad news about my health. I wish a person had delivered it

Exact Sciences stock tumbles despite strong cancer detection sales

knowledge

MassMutual is introducing free genetic testing for members

Robert Kennedy Jr.'s presidential campaign attracts GOP

Cue Health's Covid

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Close Medicare's dangerous gaps in addiction treatment coverage

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

knowledge

hotspot

hotspot

knowledge